Name | N-(1,3-dihydroxypropan-2-yl)hexadecanamide |
---|---|
Synonyms |
N-(1,3-Dihydroxy-2-propanyl)hexadecanamide
Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)ethyl]- N-palmitoylserinol Palmitoyl Serinol N-palmitoyl serinol |
Description | Palmitoyl serinol (N-Palmitoyl serinol) is an analog of the endocannabinoid N-palmitoyl ethanolamine (PEA). Palmitoyl serinol improves the epidermal permeability barrier in both normal and inflamed skin[1][2]. |
---|---|
Related Catalog | |
In Vitro | Palmitoyl serinol (N-Palmitoyl serinol) stimulates ceramide production through a CB1-dependent mechanism in in vitro model of skin inflammation[2]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 525.9±40.0 °C at 760 mmHg |
Molecular Formula | C19H39NO3 |
Molecular Weight | 329.518 |
Flash Point | 271.9±27.3 °C |
Exact Mass | 329.292999 |
PSA | 69.56000 |
LogP | 5.68 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Index of Refraction | 1.475 |
~88% 126127-31-9 |
Literature: Jupally, Vijay Reddy; Kota, Rajesh; Dornshuld, Eric Van; Mattern, Daniell L.; Tschumper, Gregory S.; Jiang, De-En; Dass, Amala Journal of the American Chemical Society, 2011 , vol. 133, # 50 p. 20258 - 20266 |
~% 126127-31-9 |
Literature: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM; HADASIT MEDICAL RESEARCH SERVICES and DEVELOPMENT LTD. Patent: WO2009/60457 A1, 2009 ; Location in patent: Page/Page column 43-44 ; |